Mouse myeloma cell line NS0-derived recombinant mouse TIMP-1. Cys25-Arg205 Accession Number P12032
Conjugate
Biotin
Applications
Application Notes
Western Blot: 1 μg/mL; ELISA Capture: 2-8 μg/mL; ELISA Detection: 0.1-0.4 μg/mL We recommend the following for sandwich ELISA (Capture - Detection): DCABY-4020 - DPABY-509
Target
Alternative Names
TIMP1; tissue inhibitor of metalloproteinase 1; EPA; Clgi; Timp; TIMP-1; TPA-S1; metalloproteinase inhibitor 1; TPA-induced protein; erythroid-potentiating activity; collagenase inhibitor 16C8 fibroblast; tissue inhibitor of metalloproteinase-1; tissue in
TIMPs-1 through -4 regulate the activity of zinc metalloproteases known as MMPs, ADAMs and ADAMTSs. Structurally, TIMPs contain two domains. The N-terminal domain binds to the active site of mature metalloproteases via a 1:1 non-covalent interaction, blocking access of substrates to the catalytic site. In addition, The C-terminal domain of TIMP-1 and TIMP-2 binds to the hemopexin- like domain of pro-MMP-9 and pro-MMP-2, respectively. The latter binding is essential for the cell surface activation of MMP-2 by MMP-14.
Pathway
Activation of Matrix Metalloproteinases; Degradation of the extracellular matrix; Extracellular matrix organization; HIF-1 signaling pathway; Hemostasis; Matrix Metalloproteinases; Platelet activation, signaling and aggregation; Platelet degranulation;
Citations
Publication ()
Have you cited DPABY-509 in a publication? Let us know and earn a reward for your research.
My Review for Anti-TIMP1 polyclonal antibody [Biotin]
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.